Table S1.
Caspase 3 cleaves Pax7 at aspartic acid D187
Start to end | Sequence | Interpretation |
188–208 | D.GILGDKGMRLDEGSDVESEPD.L | Caspase plus GluC |
188–211 | D.GILGDKGMRLDEGSDVESEPDLPL.K | Caspase plus chymotrypsin |
188–213 | D.GILGDKGMRLDEGSDVESEPDLPLKR.K | Caspase plus trypsin |
188–214 | D.GILGDKGMRLDEGSDVESEPDLPLKRK.Q | Caspase plus trypsin |
188–215 | D.GILGDKGMRLDEGSDVESEPDLPLKRKQ.R | Caspase plus GluC |
188–216 | D.GILGDKGMRLDEGSDVESEPDLPLKRKQR.R | Caspase plus trypsin |
Recombinant Pax7 was subjected to an in vitro caspase 3 cleavage assay and directly processed for LC-MS/MS and MASCOT software was used to analyze and identify peptides mapping to the Pax7 protein. The peptides identified were queried for cleavage events following an aspartic acid residues which could not be attributed to cleavage via one of the endoproteases used for LC-MS/MS processing. The resultant peptides, listed, all identified a site at D187, which identifies it as a caspase 3 cleavage site.